Penn's Gene Therapy Program lays off 84 workers, citing 'financial constraints' The Daily Pennsylvanian
Here is the original post:
Penn's Gene Therapy Program lays off 84 workers, citing 'financial constraints' - The Daily Pennsylvanian
UChicago Medicine among the first in the country to offer newly approved sickle cell gene therapies UChicago Medicine
FDA Approves Two Gene Therapies to Treat Sickle Cell Disease Including a CRISPR-Based Therapy Foley & Lardner LLP
Read the original post:
FDA Approves Two Gene Therapies to Treat Sickle Cell Disease Including a CRISPR-Based Therapy - Foley & Lardner LLP
Continued here:
Game-changer: The Hindu Editorial on approval for gene therapy to treat sickle cell disease and beta thalassemia - The Hindu
The F.D.A. Approved Gene Editing Therapy for Sickle Cell Disease The New York Times
Read more from the original source:
The F.D.A. Approved Gene Editing Therapy for Sickle Cell Disease - The New York Times
FDA approves two sickle cell therapies, including first CRISPR medicine The Washington Post
Read more from the original source:
FDA approves two sickle cell therapies, including first CRISPR medicine - The Washington Post
Forge Biologics Announces Publication in Human Gene Therapy on a Novel Finding That Changes a Fundamental ... Business Wire
Excerpt from:
Forge Biologics Announces Publication in Human Gene Therapy on a Novel Finding That Changes a Fundamental ... - Business Wire
FDA Approves First Two Sickle Cell Gene Therapies Barron's
See the original post here:
FDA Approves First Two Sickle Cell Gene Therapies - Barron's
Two Gene Therapies for Sickle Cell Disease Get FDA Nod, Including First Ever CRISPR-Based Therapy Inside Precision Medicine
Original post:
Two Gene Therapies for Sickle Cell Disease Get FDA Nod, Including First Ever CRISPR-Based Therapy - Inside Precision Medicine
First FDA approved gene therapies for sickle cell anemia cost millions Business Insider
Read this article:
First FDA approved gene therapies for sickle cell anemia cost millions - Business Insider
Cell and Gene Therapy: $27 Billion in Q1-Q3 2023 Funding PR Web
Read this article:
Cell and Gene Therapy: $27 Billion in Q1-Q3 2023 Funding - PR Web
FDA approves first cell-based gene therapies for sickle cell disease European Pharmaceutical Review
See original here:
Plakophilin 2 gene therapy prevents and rescues arrhythmogenic right ventricular cardiomyopathy in a mouse model ... - Nature.com
U.S. poised to approve first gene-editing treatment in breakthrough for sickle cell patients CNBC
Follow this link:
U.S. poised to approve first gene-editing treatment in breakthrough for sickle cell patients - CNBC
University of Pennsylvania Gene Therapy Program cuts staff by 25%, report says The Business Journals
See the article here:
University of Pennsylvania Gene Therapy Program cuts staff by 25%, report says - The Business Journals
FDA approves first cell-based gene therapies for sickle cell disease New Atlas
Go here to read the rest:
FDA approves first cell-based gene therapies for sickle cell disease - New Atlas
Synplogen and Ginkgo Bioworks Announce Plans to Accelerate Global DNA Manufacturing and Gene Therapy ... PR Newswire
See original here:
Synplogen and Ginkgo Bioworks Announce Plans to Accelerate Global DNA Manufacturing and Gene Therapy ... - PR Newswire
EMA Verdict Due On Vertex/CRISPR's Gene Editing Therapy & Reata's Omaveloxolone Pink Sheet
Read more:
EMA Verdict Due On Vertex/CRISPR's Gene Editing Therapy & Reata's Omaveloxolone - Pink Sheet
Gene Therapy, Innovative Drugs, Surgical Techniques, and the Evolving Landscape of Epilepsy Care: Gregory Krauss ... Neurology Live
See the original post here:
Gene Therapy, Innovative Drugs, Surgical Techniques, and the Evolving Landscape of Epilepsy Care: Gregory Krauss ... - Neurology Live
Early trials show promise for innovative gene therapy in lung cancer treatment WJAR
Continue reading here:
Early trials show promise for innovative gene therapy in lung cancer treatment - WJAR